Skip to search formSkip to main contentSkip to account menu

quinagolide

Known as: N,N-diethyl-N'-(1,2,3,4,4a,5,10,10a-octahydro-6-hydroxy-1-propyl-3-benzo(g)quinolinyl)sulfamide, (3alpha,4aalpha,10abeta)-(+-)-isomer, quinagolide, (3alpha,4aalpha,10abeta)-(+-)-isomer 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (2)

AminoquinolinesDopamine Agonists

Narrower (1)

quinagolide hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
Quinagolide compared with cabergoline in the prevention of ovarian hyperstimulation syndrome: a randomized trial
Objective The aim of the present study was to compare quinagolide with cabergoline in the prevention of ovarian hyperstimulation… 
2015
2015
Drug-device unit containing quinagolide
The present invention, pharmaceutical polymeric drug-based on the particular appropriate for use in a device unit, and to provide… 
2014
2014
Management of Hyperprolactinaemia
Excessive prolactin secretion is a not infrequent cause of anovulation and consequent infertility, often associated with… 
2011
2011
P-508 Quinagolide reduces Ohss in high risk Icsi patients
Introduction: Ovarian hyperstimulation syndrome (OHSS) is apotentially life-threatening iatrogenic complication of controlled… 
2010
2010
Macroprolactinaemiával társuló hypophysismacroadenoma kezelése quinagoliddal
A jelenlegi általános nézet szerint a makroprolaktin biológiailag inaktív molekula, ezért szérumkoncentrációjának növekedése… 
2008
2008
Tratamiento de la infertilidad asociada a hiperprolactinemia. Análisis de costo-efectividad en una población asegurada del ISSSTE
Introduction: In women, hyperprolactinemia is a cause of infertility. Objetive: To estimate the cost effectiveness of the use of… 
2003
2003
Tissue-polypeptide-specific antigen in SLE patients treated with low doses of quinagolide.
Sir — A potential association between neoplasms and autoimmune diseases has been postulated for years and there are instances in… 
2002
2002
MR imaging of pituitary adenomas treated with the prolactin inhibitor quinagolide
Purpose: To evaluate the volume of micro- and macroadenomas in quinagolide-treated patients with resistance to or intolerance of… 
1998
1998
A thyrotropin-secreting pituitary adenoma as a cause of thysrotoxic periodic paralysis
1997
1997
Prolactinomas apparently resistant to quinagolide respond to cabergoline therapy.
patientswithelevatedcalcitoninlevelswerefoundtohavedifferentiatedthyroidcarcinoma…